Find out more about the science behind our ideas and how we turn it into value.
During the event:
- we will tell you about our innovations,
- we will present aptamer projects, including targeted chemotherapy with aptamers,
- we will explain how our binding molecules are generated and validated: antibodies and aptamers,
- we will show the key milestones and their impact on the value of projects…
- and we will answer all your questions.
Dr. Filip Jeleń, Co-founder, President of the Board
Dr. Pieter Spee, Chief Scientific Officer
Dr. Ewelina Świderek, Head of the Aptamer Portfolio
Dr. Tomasz Klaus, Research Group Leader – Antibodies
Dr. Agnieszka Sok-Grochowska, Research Group Leader – Aptamers
📅 14 December 2021, Tuesday